{
  "trial_id": "NCT02648204",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, HbA1c levels, duration of diabetes, baseline metformin dose, renal function (eGFR), history of pancreatitis, family or personal history of Multiple Endocrine Neoplasia Type 2 or Medullary Thyroid Carcinoma, presence of proliferative retinopathy or maculopathy, history of malignant neoplasms, New York Heart Association classification, baseline weight, baseline BMI, baseline blood pressure, baseline lipid profile.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Glycosylated haemoglobin (Hb1Ac)",
          "HbA1c levels"
        ],
        [
          "Body weight",
          "baseline weight"
        ],
        [
          "Renal function (eGFR)",
          "renal function (eGFR)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Fasting plasma glucose"
      ],
      "remaining_candidate_features": [
        "duration of diabetes",
        "baseline metformin dose",
        "history of pancreatitis",
        "family or personal history of Multiple Endocrine Neoplasia Type 2 or Medullary Thyroid Carcinoma",
        "presence of proliferative retinopathy or maculopathy",
        "history of malignant neoplasms",
        "New York Heart Association classification",
        "baseline BMI",
        "baseline blood pressure",
        "baseline lipid profile"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline HbA1c, Duration of Diabetes, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, eGFR, Daily Metformin Dose,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Glycosylated haemoglobin (Hb1Ac)",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Body weight",
        "Fasting plasma glucose"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Duration of Diabetes",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "eGFR",
        "Daily Metformin Dose"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Gender, Ethnicity (NIH/OMB), Region of Enrollment, Diabetes duration, HbA1c, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, eGFR, Metformin dose,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Ethnicity (NIH/OMB)"
        ],
        [
          "Glycosylated haemoglobin (Hb1Ac)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)",
        "Body weight",
        "Fasting plasma glucose"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Diabetes duration",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "eGFR",
        "Metformin dose"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, HbA1c, fasting plasma glucose, systolic blood pressure, diastolic blood pressure, heart rate, waist circumference, smoking status, medical history (including cardiovascular disease, hypertension, dyslipidemia), concomitant medications, metformin dose.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Glycosylated haemoglobin (Hb1Ac)",
          "HbA1c"
        ],
        [
          "Fasting plasma glucose",
          "fasting plasma glucose"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Body weight"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of type 2 diabetes",
        "systolic blood pressure",
        "diastolic blood pressure",
        "heart rate",
        "waist circumference",
        "smoking status",
        "medical history (including cardiovascular disease, hypertension, dyslipidemia)",
        "concomitant medications",
        "metformin dose"
      ]
    }
  }
}